The integrated multi‐omics analysis revealed that despite the heterogeneities observed in certain omics, low expression of ZNF521 and loss of KDM6A copy number were consistently presented within and across individual tumours, serving as potential biomarkers for PDAC. This evidence concerns the gene ZNF521 and neoplasm.